Charterhouse Challenges

Our new Charterhouse Challenges programme of debates invite guest expert chairs to set our research community a challenge at the edge of what’s possible in science, tech and social innovation. Each evening, an expert in their field will introduce their take on a health innovation mission, followed by bold solutions from emerging and established talent across the disciplines. Then the discussion will open up to the floor and our invited guests.

Held at the Barts Pathology Museum in St Barts Hospital, Smithfield, London - England's oldest purpose-built medical school - these events will be filmed and made available online for all.

This year will focus on how next-generation research and innovation can create an inclusive pro-health society with a national health service fit for the 21^st century. Enquiries to: research-events@qmul.ac.uk.

UK Life Sciences as an engine for growth and wellbeing: Spotlight on Whitechapel

19th March 2025, chaired by Michael Peel, Science Editor, Financial Times. The Life Sciences sector is one of the “great drivers of growth in the 21st century” and the UK with its top research talent and wealth of data and infrastructure should be a leading player. Can Life Sciences benefit local citizens and patients as well as boosting national growth?

Can we trust AI with our health?

9th April 2025, chaired by Professor Charlotte Deane, Chief Executive, EPSRC. Healthcare innovation rests on public acceptance of AI, and that is declining at sharp rate across all ages and backgrounds. What is at the root of the public's distrust of AI in health and care? And what will it take for governments and innovators to win them over to AI adoption in health care in the UK?

Luxury wellness or common wealth? Who owns the future of personalised health

21st May 2025, chaired by Professor Jimmy Volmink, Executive Director Equity, Wellcome. From mental health to the food we eat, an explosion of wellbeing apps mean that personalised health is now in our pockets. How do we ensure that personalised health reaches those who need it most alongside driving innovation for growth and wellbeing?